2023
Impact of Visit Volume on the Effectiveness of Electronic Tools to Improve Heart Failure Care
Mukhopadhyay A, Reynolds H, King W, Phillips L, Nagler A, Szerencsy A, Saxena A, Klapheke N, Katz S, Horwitz L, Blecker S. Impact of Visit Volume on the Effectiveness of Electronic Tools to Improve Heart Failure Care. JACC Heart Failure 2023, 12: 665-674. PMID: 38043045, DOI: 10.1016/j.jchf.2023.11.002.Peer-Reviewed Original ResearchMineralocorticoid antagonistsVolume groupVisit volumeElectronic health record toolsPhysician workloadGuideline-recommended therapiesReduced ejection fractionUsual care armHeart failure carePrespecified subgroup analysisHigh-volume groupCluster-randomized trialLog-binomial modelsBusy practice settingsCare armEHR alertUsual careEjection fractionHeart failureSubgroup analysisEHR toolsNumber of visitsCardiology officePractice settingsStudy period
2022
Comparative Effectiveness and Safety of Seizure Prophylaxis Among Adults After Acute Ischemic Stroke
Moura L, Donahue M, Yan Z, Smith L, Hsu J, Newhouse J, Schwamm L, Haneuse S, Hernandez-Diaz S, Blacker D. Comparative Effectiveness and Safety of Seizure Prophylaxis Among Adults After Acute Ischemic Stroke. Stroke 2022, 54: 527-536. PMID: 36544249, PMCID: PMC9870933, DOI: 10.1161/strokeaha.122.039946.Peer-Reviewed Original ResearchConceptsSeizure prophylaxisRisk differenceAntiseizure drugsEarly seizure prophylaxisSevere AIS patientsAcute ischemic strokePrespecified subgroup analysisHealth care factorsInverse probability weightsElectronic health recordsAIS admissionsPoststroke mortalityStroke RegistryIschemic strokeAIS patientsStroke settingsCare factorsSubgroup analysisProphylaxisMortality riskHigh riskPatientsComparative effectivenessExcess deathsTrial data
2021
Effect of the STAMP (Sharing and Talking About My Preferences) Intervention on Completing Multiple Advance Care Planning Activities in Ambulatory Care : A Cluster Randomized Controlled Trial.
Fried TR, Paiva AL, Redding CA, Iannone L, O'Leary JR, Zenoni M, Risi MM, Mejnartowicz S, Rossi JS. Effect of the STAMP (Sharing and Talking About My Preferences) Intervention on Completing Multiple Advance Care Planning Activities in Ambulatory Care : A Cluster Randomized Controlled Trial. Annals Of Internal Medicine 2021, 174: 1519-1527. PMID: 34461035, PMCID: PMC8711627, DOI: 10.7326/m21-1007.Peer-Reviewed Original ResearchConceptsAdvance care planning activitiesCare planning activitiesAmbulatory care settingsAdvance care planningCare planningCare settingsNon-English speaking participantsSpecialty care practicesUsual care sitesPrespecified subgroup analysisPatient sociodemographic informationNational InstituteParticipant-level analysesQuantity of lifeHealth care agentSecondary outcomesUsual carePrimary outcomeControlled TrialsMean ageSubgroup analysisBlinded interviewersAmbulatory careCare sitesPrint intervention
2018
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Kasner S, Swaminathan B, Lavados P, Sharma M, Muir K, Veltkamp R, Ameriso S, Endres M, Lutsep H, Messé S, Spence J, Nedeltechev K, Perera K, Santo G, Olavarria V, Lindgren A, Bangdiwala S, Shoamanesh A, Berkowitz S, Mundl H, Connolly S, Hart R, Abdelhamid N, Rahman D, Abdul-Saheb M, Abreu P, Abroskina M, Abu Ahmad F, Accassat S, Acciaresi M, Adami A, Ahmad N, Ahmed F, Hawkes M, Alemseged F, Ali A, Altavilla R, Alwis L, Amarenco P, Amaro S, Sanchez L, Pinto A, Ameriso S, Amin H, Amino T, Amjad A, Anagnostou E, Andersen G, Anderson C, Anderson D, Falco M, Mackinnon F, Andreu D, Androulakis M, Gamero M, Saredo G, Diaz R, Font M, Anticoli S, Arauz A, Gongora A, Araya P, Lara J, Rivas S, Arnold M, Augustin S, Avelar W, Azevedo E, Babikian V, Bacellar A, Badalyan K, Bae H, Martinez E, Bagelmann H, Bailey P, Bak Z, Baker M, Balazs A, Baldaranov D, Balogun I, Balueva T, Bankuti Z, Bar M, Baranowska A, Bardutzky J, Trejo S, Barlinn J, Baronnet F, Barroso C, Barteys M, Bartolottiova T, Barulin A, Bas M, Bashir S, Basile V, Bathe-Peters R, Bathula R, Batista C, Caglayan H, Baumgartner P, Bazan R, Bazhenova O, Beaudry M, Beer J, Behnam Y, Beilei C, Beinlich A, Bejot Y, Belkin A, Benavente O, Benjamin A, Berardi V, Bereczki D, Berkowitz S, Berlingieri J, Berrios W, Berrouschot J, Bhandari M, Bhargavah M, Bicker H, Bicsak T, Bilik M, Bindila D, Birchenall J, Birnbaum L, Black T, Blacker D, Blacquiere D, Blanc-Labarre C, Blank C, Blazejewska-Hyzorek B, Bloch S, Bodiguel E, Bogdanov E, Boos L, Borcsik L, Bornstein N, Bouly S, Braga G, Bragado I, Bravi M, Brokalaki C, Brola W, Brouns R, Bruce D, Brzoska-Mizgalska J, Buck B, Buksinska-Lisik M, Burke J, Burn M, Bustamante G, Cabrejo L, Cai K, Cajaraville S, Calejo M, Calvet D, Campillo J, Costa E, Camps P, Alaydin H, Candeloro E, Canepa C, Brito C, Cappellari M, Carcel C, Portela P, Cardoso F, Carek M, Carletti M, Portilla J, Caruso P, Casado-Naranjo I, Castellini P, Castro D, Meira F, Cavallini A, Caudevilla N, Cenciarelli S, Cereda C, Cerrone P, Chakrabarti A, Chaloulos-Iakovidis P, Chamorro A, Chandrasena D, Chang D, Che C, Chembala J, Chen J, Chen Z, Chen T, Chen H, Chen X, Chen G, Chen L, Chen S, Chen J, Chen L, Chen S, Cheripelli B, Chin M, Anaya E, Chorazy M, Christensen H, Christensen T, Christian L, Chu F, Chung C, Clark W, Clarke R, Claverie S, Agostoni E, Clissold B, Coelho J, Cohen D, Colakoglu S, Collas D, Condurso R, Connolly S, Consoli D, Constantin C, Silva C, Contardo L, Corlobe A, Correia M, Correia C, Garcia E, Coull B, Coutts S, Coveney S, Cras P, Crols R, Crozier S, Csanyi A, Csiba L, Csontos K, Csuha R, Cui L, Cunha L, Curtze S, Czerska M, Czlonkowska A, Czurko M, Czuryszkiewicz M, Dagnino M, Dai C, Daineko A, Dalek G, Damgaard D, Danese A, Dani K, Danku V, Toledo W, Dávalos A, De Havenon A, De Keyser J, De Klippel N, De La Torre J, De Pauw A, De Smedt A, De Torres R, De Vries Basson M, Dearborn J, Deganutto R, Degeorgia M, Deguchi I, Del Giudice A, Delcourt C, Delgado-Mederos R, Della Marca G, Delpont B, Deltour S, Demets D, Dennis M, Desai J, Devine J, Dhollander I, Di Mascio M, Diaconu M, Otero F, Dietzel J, Diez-Tejedor E, Ding N, Ding J, Ding J, Diomedi M, Dioszeghy P, Distefano M, Domigo V, Dorodnicov E, Dossi D, Doubal F, Druzenko I, Du P, Du J, Duman T, Duodu Y, Dutta D, Dylewicz L, Eckstein J, Ehrensperger E, Ehrlich S, Allende G, Halac B, Elyas S, Endres M, Engelbrecht J, Engelter S, Epinat M, Eren F, Esbjornsson M, Escribano B, Escudero I, Esisi B, Essa B, Esterbauer M, Evans N, Eveson D, Fabio S, Fang L, Fanta S, Fares M, Fatar M, Faust K, Favate A, Fazekas F, Denaro M, Fedin A, Amaya P, Feng J, Ferencova K, Gilli M, Fernandez, Pirrone P, Vera J, Ferrari J, Ferreira A, Ferreira G, Fidler M, Field D, Field T, Figueroa C, Fiksa J, Filipov A, Firstenfeld A, Fisch L, Fischer U, Fisselier M, Fiszer U, Fluri F, Fortea G, Fotherby K, Fraczek A, France E, Freitas G, Frey S, Frick M, Friedman A, Friedrich M, Frisullo G, Fryze W, Gimeno B, Fujigasaki H, Fukuyama K, Furlan A, Furlanis G, Furnace J, Gabriel M, Reich E, Gagliardi R, Galati F, Giqueauk E, Gallina A, Gallinella E, Gallo J, Gangadharan S, Gao Y, Lopez R, Pastor A, Sanchez S, Garnauf M, Garnier P, Gasecki D, Gasic K, Gasiorek K, Gasser S, Gaugg M, Gebreyohanns M, Gebura K, Geng J, Clavijo M, Haeusler K, Geran R, Geremek M, Gerocs Z, Ghia D, Giannandrea D, Giatsidis F, Lopez J, Nunez A, Gimenez L, Giralt E, Glabinski A, Gladstone D, Gliem M, Gluszkiewicz M, Goddeau R, Gogoleva E, Gokce M, Goldemund D, Golikov K, Neto A, Schneider M, Gomez-Choco M, Gomis M, Gongora-Rivera J, Gonysheva Y, Gonzalez L, Toledo M, Gottschal M, Gozdzik I, Grabowski S, Graf S, Green D, Greer D, Gregorio T, Greisenegger S, Greshnova I, Griebe M, Grzesik M, Guan J, Guarda S, Gueguen A, Guidoux C, Povedano P, Guillon B, Guiraudg V, Gunathilagan G, Guryanova N, Gusev V, Persi G, Gutiérrez R, Guyler P, Gyuker N, Hachinski V, Hajas A, Hallevi H, Hankey G, Hankey G, Hanouskova L, Hao L, Haraguchi K, Sreekantaiah Y, Haratz S, Hargroves D, Harkness K, Harmel P, Harrasser M, Hart R, Harvey M, Hasan R, Hasegawa Y, Hassan A, Hattori M, Hatzitolios A, Hauk M, Hayashi T, Hayhoe H, Hedna V, Heine M, Held V, Hellwig S, Henkner J, Henninger N, Hermans S, Hernandez J, Herrero D, Hervieu-Begue M, Herzig R, Hicken L, Hieber M, Hill M, Hirose M, Hobeanu M, Hobson B, Hochstetter M, Heo J, Hoffmann M, Holmstedt C, Hon P, Hong K, Honma Y, Horev A, Horgan G, Horvath L, Horvath M, Hoyer C, Huang D, Huang H, Huber B, Huhtakangas J, Hussain M, Igarashi S, Mohedano A, Tembl J, Impellizzeri M, Inanc Y, Ioli P, Aniculaesei A, Ishida K, Itabashi R, Iversen H, Jagolino A, Jakab K, Jander S, Janka H, Jankovych J, Jansen J, Jasek L, Alet M, Javor L, Jin X, Jing P, Joachim B, Macleod M, Johnson M, Martin J, Joyner C, Szabo K, Jun-Oconnell A, Jura R, Kaczorowska B, Kadlcikova J, Kahles T, Kakaletsis N, Kakuk I, Kalinowska K, Kaminska K, Kaneko C, Kanellos I, Kapeller P, Kapica-Topczewska K, Karasz O, Karlinski M, Karlsson J, Kasa K, Kashaeva E, Kasner, Kaste M, Kasza J, Iljicsov A, Katsurayama M, Kaur S, Kawanishi M, Kaygorodtseva S, Ke K, Kei A, Keilitz J, Kellner J, Kelly P, Kelly S, Kemlink D, Kerekgyarto M, Keskinarkaus I, Khairutdinova D, Khanna A, Khaw A, Kholopov M, Khoumri C, Kirpicheva S, Kirshner H, Kitagawa K, Kittner S, Kivioja R, Klein F, Kleindorfer D, Kleinig T, Klivenyi P, Knecht S, Kobayashi Y, Kobayashi A, Koch M, Koehler L, Koivu M, Kolianov V, Koltsov I, Kondo T, Konkov I, Kopecky S, Korompoki E, Korpela J, Kosarz-Lanczek K, Koutroubi A, Kovacs K, Kovacs T, Kovacs H, Kowalczyk K, Kowalska M, Krajickova D, Kral M, Hansen C, Kraska J, Krebs S, Krejci V, Kremer C, Kreuzpointer R, Krzyzanowska M, Kucken D, Kulakowska A, Kunzmann J, Kurenkova N, Kuris A, Kurkowska-Jastrzebska I, Kurtenkova N, Kurushina O, Kusnick G, Kustova M, Kuwashiro T, Kwan J, Lago A, Lagutenko M, Lajos B, Lambeck J, Lamy C, Landolfi A, Lanfranconi S, Lang W, Lezama L, Rodriguez B, Largo T, Lasek-Bal A, Latte L, Lauer V, Lavados P, Le Bouc R, Cantu R, Lechner H, Lecouturier K, Leder S, Lee J, Lee B, Leger A, Leira E, Leisse I, Leker R, Lembo G, Lenskaya L, Leyden J, Li G, Li M, Li S, Li J, Liamis G, Liang H, Liang Z, Ligot N, Lin H, Lindert R, Lindgren A, Linna M, Litwin T, Liu K, Liu X, Llull L, Lohninger B, Longoni M, Loomis C, Lopes D, Fernandez M, Garza N, Lord A, Louw S, Lovasz R, Lowenkopf T, Lu Z, Lubke-Detring S, Luder R, Lujan S, Luo B, Lupinogina L, Luschin G, Lutsep H, Lvova A, Ly J, Grosse G, Ma H, Ma C, Machado M, Machado C, Macher S, Machetanz J, Macian-Montoro F, Mackey E, Mackey A, Maclean G, Maestre-Moreno J, Magadan A, Magyar T, Mahagney A, Majid A, Majjhoo A, Makaritsis K, Mandzia J, Guijarro M, Mangion D, Manios E, Mann S, Manning L, Manno C, Garcia J, Maqueda V, Castellanos M, Freijo M, Marando C, Lepera S, Couto J, Bruera G, Greco L, Lorenzo A, Obmann S, Roa A, Marini C, Marinkovic I, Sumay G, Torres C, Marko M, Markova S, Markus H, Marsh R, Marsili E, Esnaola M, Moreno J, Marti-Fabregas J, Angelocola S, Sánchez P, Martinez-Majander N, Martins S, Marzelik O, Mastrocola S, Matamala G, Matoltsy A, Matosevic B, Matsumoto S, Maud A, Cabdevila G, May Z, Mayasi Y, Mayr A, Mazzoli T, Mcarthur K, Mccullough L, Pech C, Medlin F, Mehdiratta M, Mehta S, Mehta D, Mehta B, Melis M, Melnikova E, Mendez B, Mendonca T, Chirifie J, Menon N, Mensch A, Meseguer E, Messe S, Metcalf K, Meyer N, Michas F, Micheletti N, Mikulik R, Milionis H, Miller B, Milling T, Minelli C, Minhas J, Minns M, Mircea D, Mishra S, Mismas A, Mistri A, Mitrovic N, Miyake H, Modrau B, Moey A, Molina C, Molina J, Molis A, Moller J, Molnar S, Moniche F, Monosi C, Monzani V, Moonis M, Morais R, Morales L, Morales A, Morar-Precup D, Moreton F, Moro C, Morozova E, Morton M, Morvan T, Morvan E, Motko T, Mowla A, Mozhejko E, Muddegowda G, Mudhar O, Mueller T, Muhl C, Muir K, Mundl H, Munoz S, Murphy C, Murphy S, Murtuzova A, Musuka T, Mutzenbach J, Myint M, Mysliwy W, Naccarato M, Naeije G, Nagakane Y, Natarajan I, Navaratnam D, Nave A, Nazliel B, Nedeltchev K, Nel J, Nell H, Nemeth R, Nemeth L, Neto O, Ng K, Ngeh J, Chialvo L, Nieminen T, Nikkanen M, Nikl J, Nikoforova M, Nishino S, Nishiyama Y, Njovane X, Nogawa S, Nombela F, Norrving B, Nosek K, Nowak B, Nowakowska-Sledz E, Ntaios G, Numminen H, Nunez F, Obadia M, Oberndorfer S, Obrezan A, Ochiai J, Oczkowski W, O'Donnell M, Odyniec A, Oh K, Ohira M, Okamoto Y, Okpala M, Okubo S, Olah L, Olavarria V, Oleszek J, Demirci N, Ondar V, Ongun G, Ooyama K, Orosz V, Ortiz R, Osseby G, Österlund-Tauriala E, Ovesen C, Demirhan S, Ozdoba-Rot J, Ozturk S, Ozyurt E, Grecco M, Povedano G, Paciaroni M, Padiglioni C, Pagola J, Palasik W, Panczel G, Panos L, Papadopoulos G, Papadopoulou E, Papagiannis A, Papavasileiou V, Papina M, De Donlebun P, Parisi V, Park J, Pasten J, Patel N, Pavlik O, Pawelczyk M, Peacock W, Pei H, Peisker T, Sedna L, Penn A, Pentek S, Pepper E, Pereira L, Perera K, Perez Y, Perez S, Leguizamon P, Pernicka M, Perry R, Persico A, Pesant Y, Peska S, Peters D, Peters G, Pettigrew L, Phan T, Philippi S, Phinney T, Pico F, Pidal A, Piechowski-Jozwiak B, Pieroni A, Pineiro S, Piras V, Pizova N, Polanco J, Polin M, Polyakov A, Polychronopoulou E, Polymeris A, Popov D, Poppe A, Postorino P, Pozzerese C, Pradhan M, Prats L, Prazdnichkova E, Prendl B, Pretorius M, Profice P, Prokopenko S, Pudov E, Lereis V, Bravo G, Purroy F, Qiu J, Qu X, Quenardelle V, Garcia H, Radrizzani L, Radtke A, Raffelsberger T, Moreno J, Ramos-Estebanez C, Rani A, Rapantova P, Rashed K, Nihara A, Rasmussen J, Robles L, Reif M, Reiner P, Rekova P, Renu A, Repetto M, Reyes P, Morales S, Rha J, Ribeiro J, Ricci S, Richard C, Rigual R, Rinaldi C, Rodriguez C, Rizzato B, Robinson T, Rocco A, Rodrigues M, Rodriguez G, Campello A, Lucci F, Yanez M, Roesler C, Roffe C, Roine R, Roine S, Roldan A, Pezzella F, Romano M, Roos J, Rosso C, Kruuse C, Roth Y, Roukens R, Roveri L, Rozanski D, Rozniecki J, Rozsa C, Rudilosso S, Ares G, Franco A, Rum G, Ruuskanen J, Rybinnik I, Ryota K, Saarinen J, Saavedra V, Sabben C, Sabet A, Sagris D, Sahlas J, Sakai N, Salamanca P, Salgado P, Salig S, Salletmayr T, Salnikov M, Samoshkina O, Samson Y, Sanak D, Cerón M, Santalucia P, Cadavid M, Santiago P, Santo G, Cuesta B, Sargento J, Sarraj A, Sas K, Sas A, Satoshi O, Satsoglou S, Sattar N, Savitz S, Savopoulos C, Saw J, Sawicka M, Sawyer R, Scandura T, Schillinger N, Schindler J, Schlachetzki F, Schneider I, Schuppner R, Schurig J, Schwarzbach C, Sebejova M, Seidel G, Sekaran L, Selcuk D, Selvarajah J, Semerano A, Semjen J, Semushina D, Sen S, Park M, Serena J, Tokgoz O, Serles W, Serrano F, Sevin M, Seynaeve L, Shah S, Shamalov N, Shang T, Sharma M, Sharrief A, Hussain M, Shchukin I, Shen W, Shepeleva E, Shinsuke I, Shmonin A, Shoamanesh A, Shuaib A, Shulga A, Sibolt G, Sibon I, Sicilia I, Siebert M, Sieczkowska E, Sila C, Silva A, Silva D, Silva P, Silva Y, Silvestrini M, Simony Z, Simpkins A, Singh B, Sinha D, Sipos I, Skoda O, Skowron P, Skowronska M, Sliwinska B, Slonkova J, Smolkin A, Smyth A, Sobolewski P, Sobota A, Sohn S, Soldatov M, Solganov I, Soloveva L, Solovyeva E, Sonntag N, Soors P, Sorgun M, Soriano C, Spence D, Spengos K, Sposato L, Staaf G, Stadler K, Stakhovskaya L, Stamatelopoulos K, Steinert S, Stetkarova I, Stiehm M, Stocker R, Stoinski J, Stoll A, Stotts G, Stumpp A, Sucapane P, Suenaga T, Sun X, Sundararajan S, Kim J, Suzuki H, Svaneborg N, Szasz G, Szczuchniak W, Szczyrba S, Szegedi N, Szekely A, Szewczyk Z, Szilagyi G, Szlufik S, Szoboszlai K, Szpisjak L, Sztajzel R, Sztriha L, Wil T, Taggeselle J, Takamatsu K, Takao M, Taki W, Takizawa S, Talahma M, Tamayo A, Tan J, Tanne D, Tapanainen A, Tapiola T, Tarasiuk J, Tatlisumak T, Tayal A, Tcvetkova S, Teal P, Garcia J, Meza H, Tenora D, Terceno M, Terentiou A, Tezcan S, Thaler D, Thomson A, Thouvenot E, Tiainen M, Timberg I, Timsit S, Tinchon A, Tirschwell D, Isikay C, Tokunaga K, Tolino M, Toloza C, Tomelleri G, Tomoyuki K, Tomppo L, Tong Z, Tong L, Toni D, Torres J, Tossavainen C, Toth G, Tountopoulou A, Touze E, Tovar M, Toyoda K, Trillo S, Trommer A, Tropepi D, Tryambake D, Tu H, Tuetuencue S, Tumova R, Tumpula O, Turc G, Tutaj A, Tynkkynen J, Uchiyama S, Uchwat U, Uhrinyakova L, Acar R, Ugurlu D, Urra X, Urui S, Ruiz M, Vaclavik D, Vahedi K, Valikovics A, Valpas J, Van Acker P, Van Daele W, Vanderschueren G, Jure L, Varela R, Varga Z, Varvat J, Varvyanskaya N, Salgado A, Vasko P, Vass L, Vassilopoulou S, Vastagh I, Vazquez P, Vecsei L, Veltkamp R, Venti M, Verdugo M, Verocai V, Marroquin M, Simonsini C, Veverka T, Vigl M, Vila A, Vilar C, Osorio J, Virta J, Vitkova E, Voglsperger B, Volna J, Von Weitzel-Mudersbach P, Vora N, Voznyuk I, Wach-Klink A, Wacongne A, Walters D, Wang Y, Wang J, Wang L, Wang X, Wang W, Wang N, Wang D, Wang H, Wang H, Wang X, Wang Y, Wang Y, Warnack W, Wartenberg K, Waters R, Waters M, Webb T, Weber J, Weiss G, Weissenborn K, Weitz J, Weller B, Wen G, Weng G, Werner P, Werring D, Wester P, Whiteley W, Whiting R, Wijeratne T, Willems C, Wilson L, Wilson C, Winder T, Windt J, Winkler A, Winska-Tereszkiewicz A, Wisniewska A, Wittayer M, Wlodek A, Wojnarowska-Arendt A, Wolf M, Wolff V, Wolter C, Wong A, Nah H, Worthmann H, Wu W, Wu S, Wunderlich S, Wurzinger H, Wyse D, Xiao B, Xiaopeng W, Ximenez-Carrillo A, Xiong L, Xiong Y, Xiong W, Xu Y, Xu J, Xu Z, Yalo B, Yamada T, Yamasaki M, Yang L, Yang Y, Yang X, Yang Q, Yang B, Yang J, Yang J, Yasuhiro I, Lam M, Yegappan C, Yip S, Ylikallio E, Ylikotila P, Jin A, Yoon B, Yoshida Y, Yperzeele L, Yuan H, Yuasa H, Zalewska J, Zanferrari C, Zapata E, Zboznovits D, Zelenka I, Zhang C, Zhang B, Zhang S, Zhang M, Zhang X, Zhang J, Zhao L, Zhirnova O, Zhou L, Zielinska-Turek J, Zinchenko I, Ziomek M, Zitzmann A, Zweifler R, Zwiernik J. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. The Lancet Neurology 2018, 17: 1053-1060. PMID: 30274772, PMCID: PMC6662613, DOI: 10.1016/s1474-4422(18)30319-3.Peer-Reviewed Original ResearchConceptsRecurrent ischemic strokePrespecified subgroup analysisIschemic strokeNAVIGATE ESUS trialAntiplatelet therapyTransthoracic echocardiographyTransoesophageal echocardiographySubgroup analysisNAVIGATE ESUSMajor bleedingRecurrent strokeEmbolic strokeUndetermined sourceRecurrent ischemic stroke ratesOral factor Xa inhibitorsSafety of rivaroxabanPrimary efficacy outcomePrimary safety outcomeSecondary stroke preventionPhase 3 trialIschemic stroke ratePatent foramen ovaleEarly trial terminationSummary odds ratiosFactor Xa inhibitorsDocetaxel with or without ramucirumab after immune checkpoint inhibition in platinum-refractory metastatic urothelial carcinoma (mUC): Prespecified subgroup analysis from the phase 3 RANGE trial.
Drakaki A, Kirby C, Van Der Heijden M, Petrylak D, Powles T, Chi K, Flechon A, Necchi A, Geczi L, Lee J, Gakis G, Bracarda S, Chowdhury S, Lin C, Keizman D, Vaishampayan U, Liepa A, Zimmermann A, Bell-McGuinn K, Castellano D. Docetaxel with or without ramucirumab after immune checkpoint inhibition in platinum-refractory metastatic urothelial carcinoma (mUC): Prespecified subgroup analysis from the phase 3 RANGE trial. Journal Of Clinical Oncology 2018, 36: 434-434. DOI: 10.1200/jco.2018.36.6_suppl.434.Peer-Reviewed Original ResearchPlatinum-refractory metastatic urothelial carcinomaImmune checkpoint inhibitorsMetastatic urothelial carcinomaObjective response ratePrior immune checkpoint inhibitorsLiver metastasesPD-L1Subgroup analysisDouble-blinded phase 3 trialPD-1/PD-L1Disease sitesHigher objective response ratePre-specified subgroup analysisInvestigator-assessed PFSImmune checkpoint inhibitionProgression-free survivalPhase 3 trialPrespecified subgroup analysisPlatinum-based chemotherapyFrequency of gradeICI therapyMedian PFSSecondary endpointsCheckpoint inhibitorsData cutoff
2017
Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants
Jensen E, Dysart K, Gantz M, Carper B, Higgins R, Keszler M, Laughon M, Poindexter B, Stoll B, Walsh M, Schmidt B, Network E, Caplan M, Polin R, Laptook R, Keszler M, Hensman A, Basso K, Vieira E, Little E, Fanaroff A, Hibbs A, Newman N, Truog W, Kilbride H, Pallotto E, Gauldin C, Holmes A, Johnson K, Knutson A, Schibler K, Donovan E, Alexander B, Grisby C, Hessling J, Fischer E, Jackson L, Kirker K, Muthig G, Goldberg R, Cotten C, Fisher K, Auten K, Foy K, Grimes S, Finkle J, Laughon M, Bose C, Bernhardt J, Bose G, Carlton D, Hale E, Archer S, Poindexter B, Sokol G, Wilson L, Herron D, Sánchez P, Nelin L, Jadcherla S, Luzader P, Fortney C, Besner G, Parikh N, Das A, Wallace D, Auman J, Crawford M, Huitema C, Zaterka-Baxter K, Van Meurs K, Adams M, Stevenson D, Ball M, Palmquist A, Proud M, Frantz I, Fiascone J, MacKinnon B, Nylen E, Carlo W, Ambalavanan N, Collins M, Cosby S, Devaskar U, Garg M, Chanlaw T, Geller R, Bell E, Ellsbury D, Widness J, Johnson K, Campbell D, Watterberg K, Ohls R, Lacy C, Montman R, Brown S, Wussow T, Hartenberger C, Schmidt B, Kirpalani H, DeMauro S, Chaudhary A, Abbasi S, Mancini T, Cucinotta D, D'Angio C, Guillet R, Lakshminrusimha S, Reynolds A, Reubens L, Jensen R, Maffett D, Wadkins H, Sacilowski M, Williams A, Guilford S, Horihan C, Kennedy K, Tyson J, Burson K, Harris B, McDavid G, Tate P, Wright S, Sánchez P, Brion L, Chen L, Guzman A, Leps M, Miller N, Morgan J, Vasil D, Torres L, Faix R, Yoder B, Osborne K, Bird K, Burnett J, Jensen J, Spencer C, Weaver-Lewis K, Zanetti K, Shankaran S, Barks J, Bara R, Johnson M, Christensen M, Wiggins S, Ehrenkranz R, Jacobs H, Cervone P, Konstantino M, Poulsen J, Taft J. Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. The Journal Of Pediatrics 2017, 186: 34-40.e2. PMID: 28258737, PMCID: PMC5484725, DOI: 10.1016/j.jpeds.2017.02.003.Peer-Reviewed Original ResearchConceptsProphylactic indomethacinBronchopulmonary dysplasiaPatent ductus arteriosusPreterm infantsDuctus arteriosusBirth weightLower oddsHuman Development Neonatal Research NetworkComposite of deathRetrospective cohort studyExtremely preterm infantsPrespecified subgroup analysisWeeks postmenstrual ageNeonatal Research NetworkHours of lifeFirst dayCohort studyPostmenstrual ageGestational ageSupplemental oxygenPotential confoundersSubgroup analysisLarge cohortChild healthInfants
2016
Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
Jackevicius CA, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT. Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome. Journal Of The American Heart Association 2016, 5: e003350. PMID: 27098970, PMCID: PMC4859299, DOI: 10.1161/jaha.116.003350.Peer-Reviewed Original ResearchConceptsGeneric atorvastatinACS hospitalizationSecondary outcomesClinical effectivenessAcute coronary syndrome hospitalizationPopulation-based cohort studyNew-onset diabetesAcute coronary syndromeDays of dischargePrespecified subgroup analysisPropensity-matched pairsInfrequent side effectsBrand-name medicationsSignificant differencesHealth care plansRecurrent ACSAdmission diagnosisAtorvastatin doseCardiovascular outcomesCoronary syndromeCohort studyRenal failureHeart failurePrimary outcomeMean age
2015
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009
Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009. JAMA Oncology 2015, 1: 1098. PMID: 26313372, DOI: 10.1001/jamaoncol.2015.2722.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAntineoplastic AgentsBiomarkers, TumorBreast NeoplasmsChemotherapy, AdjuvantChi-Square DistributionFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGenetic TestingGuideline AdherenceHumansInsurance BenefitsMedicareMultivariate AnalysisNeoplasm Recurrence, LocalNeoplasm StagingOdds RatioPatient SelectionPhenotypePractice Guidelines as TopicPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsSEER ProgramTime FactorsTreatment OutcomeUnited StatesConceptsReceipt of chemotherapyLower chemotherapy useHigh-risk diseasePatients 70 yearsChemotherapy useBreast cancerRecurrence scoreMedicare beneficiariesNational Comprehensive Cancer Network guidelinesEarly-stage breast cancerConsideration of chemotherapyLow-risk diseaseOverall chemotherapy useIncident breast cancerLow-risk patientsRetrospective cohort studyHigh-risk patientsPrespecified subgroup analysisUse of chemotherapyAdditional prognostic informationEnd Results (SEER) dataInvasive breast cancerRS assayNCCN riskAdjuvant chemotherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply